Stay updated with breaking news from Regenerative Cures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At Michelle Johnson's 20-week ultrasound, she received the distressing news that her developing baby was diagnosed with myelomeningocele, also known as spina bifida.
The University of California, Davis, announced the recipients of the 2022 Chancellor’s Innovation Awards at an in-person event on June 16. The awards recognize faculty, community partners and industry leaders developing innovative solutions to improve the lives of others and address important needs in our global society.
An immunotherapy treatment for blood cancers has sent one local patient into complete remission, and may eventually lead to breakthroughs.
Date Time UC Davis MIND Institute to host inaugural stem cell, gene therapy conference This fall, the UC Davis MIND Institute will host a brand-new conference focused on the development of effective genetic and stem cell treatments for children with neurodevelopmental conditions such as autism, fragile X syndrome, Rett syndrome, Dravet syndrome, Angelman syndrome and others. The inaugural Stem Cell and Gene Therapy for Neurodevelopmental Disorders Conference will be Sept. 24-25. Abstracts are currently being accepted for the inaugural Stem Cell and Gene Therapy for Neurodevelopmental Disorde...
Share this article Share this article SILVER SPRING, Md., March 3, 2021 /PRNewswire/ -- In partnership with more than 70 advocacy groups, healthcare providers, and biotech companies, the Tuberous Sclerosis Alliance (TS Alliance), an internationally recognized nonprofit that raises awareness and funds to fight the rare genetic disease tuberous sclerosis complex (TSC), recently issued a letter to the National Governors Association that calls on states to immediately prioritize Americans with life-threatening rare diseases in their COVID-19 vaccine rollouts. In late January, President Biden a...